NCCN guideline suggested EGFR testing is strongly recommended in NSCLC, EGFR-TKIs are also recommended for NSCLC patients harboring sensitizing EGFR mutation as the first-line treatment [5]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.